A US study shows that many research participants don’t want to know their risks of getting Alzheimer’s disease.

Over 6 million Americans are impacted by Alzheimer's disease, and researchers from Vanderbilt University Medical Center and ...

Scientists have discovered markedly higher PGDH levels in the brains of those with Alzheimer's disease, which fuels hope that ...

A new survey suggests almost 80% of American adults would want to know if they have Alzheimer's disease before they develop ...

A new study links prolonged sedentary behavior to increased risk of cognitive decline and brain shrinkage associated with ...

Nucleoside reverse transcriptase inhibitors -- antiretroviral drugs approved to treat HIV and hepatitis B -- were associated ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

Scientists at Northwestern University have developed a new approach that directly combats the progression of ...

Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help ...

Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare systems, and societies as populations age. Although current treatments, ...

Dementia affects people in different ways, but common early signs include confusion about time or place, memory loss, and ...

As public awareness of dementia grows, so too does the appetite for prevention. Global headlines tout the benefits of ...